BIOMAT Database Logo BIOMAT Database Logo

Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon. 1991

B Marasini, and M Cugno, and A Agostoni

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

B Marasini, and M Cugno, and A Agostoni
Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease.
January 1995, Scandinavian journal of rheumatology,
B Marasini, and M Cugno, and A Agostoni
Association of von Willebrand factor and fibrinogen plasma levels with primary Raynaud's phenomenon in male and female patients.
April 2013, Rheumatology international,
B Marasini, and M Cugno, and A Agostoni
Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.
December 1991, British journal of rheumatology,
B Marasini, and M Cugno, and A Agostoni
Comparison of von Willebrand factor and tissue plasminogen activator concentrations in plasma and serum.
June 1996, Clinical chemistry,
B Marasini, and M Cugno, and A Agostoni
Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.
September 1993, Clinical rheumatology,
B Marasini, and M Cugno, and A Agostoni
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
August 1995, Thrombosis and haemostasis,
B Marasini, and M Cugno, and A Agostoni
The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women.
May 2000, The American journal of medicine,
B Marasini, and M Cugno, and A Agostoni
Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
May 2008, Diabetes care,
B Marasini, and M Cugno, and A Agostoni
Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease.
May 2017, Haemophilia : the official journal of the World Federation of Hemophilia,
B Marasini, and M Cugno, and A Agostoni
Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke.
August 2002, Atherosclerosis,
Copied contents to your clipboard!